1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome

Pooja Kri Gupta, Sharon Barak, Yonatan Feuermann, Gil Goobes, Hanoch Kaphzan

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Angelman syndrome (AS) is a rare neurodevelopmental genetic disorder caused by the loss of function of the ubiquitin ligase E3A (UBE3A) gene, affecting approximately 1:15,000 live births. We have recently shown that mitochondrial function in AS is altered during mid to late embryonic brain development leading to increased oxidative stress and enhanced apoptosis of neural precursor cells. However, the overall alterations of metabolic processes are still unknown. Hence, as a follow-up, we aim to investigate the metabolic profiles of wild-type (WT) and AS littermates and to identify which metabolic processes are aberrant in the brain of AS model mice during embryonic development. Methods: We collected brain tissue samples from mice embryos at E16.5 and performed metabolomic analyses using proton nuclear magnetic resonance (1H-NMR) spectroscopy. Multivariate and Univariate analyses were performed to determine the significantly altered metabolites in AS mice. Pathways associated with the altered metabolites were identified using metabolite set enrichment analysis. Results: Our analysis showed that overall, the metabolomic fingerprint of AS embryonic brains differed from those of their WT littermates. Moreover, we revealed a significant elevation of distinct metabolites, such as acetate, lactate, and succinate in the AS samples compared to the WT samples. The elevated metabolites were significantly associated with the pyruvate metabolism and glycolytic pathways. Limitations: Only 14 metabolites were successfully identified and investigated in the present study. The effect of unidentified metabolites and their unresolved peaks was not determined. Additionally, we conducted the metabolomic study on whole brain tissue samples. Employing high-resolution NMR studies on different brain regions could further expand our knowledge regarding metabolic alterations in the AS brain. Furthermore, increasing the sample size could reveal the involvement of more significantly altered metabolites in the pathophysiology of the AS brain. Conclusions: Ube3a loss of function alters bioenergy-related metabolism in the AS brain during embryonic development. Furthermore, these neurochemical changes could be linked to the mitochondrial reactive oxygen species and oxidative stress that occurs during the AS embryonic development.

Original languageEnglish
Article number31
JournalMolecular Autism
Volume15
Issue number1
DOIs
StatePublished - 24 Jul 2024

Bibliographical note

Publisher Copyright:
© The Author(s) 2024.

Keywords

  • Acetate
  • Angelman syndrome
  • Developmental disorders
  • Glycolysis
  • Lactate
  • Metabolite
  • Mitochondria
  • Pyruvate metabolism
  • Reactive oxygen species
  • Succinate

ASJC Scopus subject areas

  • Molecular Biology
  • Developmental Neuroscience
  • Developmental Biology
  • Psychiatry and Mental health

Fingerprint

Dive into the research topics of '1H-NMR-based metabolomics reveals metabolic alterations in early development of a mouse model of Angelman syndrome'. Together they form a unique fingerprint.

Cite this